Skip to main content
Fig. 2 | Molecular Cancer

Fig. 2

From: LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation

Fig. 2

FEZF1-AS1 upregulation associated with tumor size, stage and poor survival of gastric cancer patients. a FEZF1-AS1 expression was classified into two groups. Final results were presented as fold change in tumor tissues relative to normal tissues. Fold change is greater than or equal to 2.0 for high expression, and less than 2.0 for low expression. b, c FEZF1-AS1 expression was correlation with tumor size and stage. d Kaplan–Meier disease-free survival curves according to FEZF1-AS1 expression levels. e ROC analysis of based on FEZF1-AS1 expression for survival prediction of patients with gastric cancer. *P < 0.05, **P < 0.01

Back to article page

Molecular Cancer

ISSN: 1476-4598